What Happens When You Stop a GLP-1 Medication?

People stop or change medications for many reasons, including side effects, cost or access, pregnancy planning, other health changes, personal preference or a clinician’s recommendation. Whatever the reason, stopping a medication used for chronic weight management deserves the same kind of planning as starting it. Do not stop or restart prescription treatment based only on an online timeline. Discuss the reason, risks and next steps with the prescribing clinician.

In an exploratory extension of STEP 1, 327 participants were followed for one year after semaglutide 2.4 mg and the study lifestyle intervention were stopped. Participants who had received semaglutide regained, on average, about two-thirds of the weight they had previously lost during treatment. Many cardiometabolic improvements also moved back toward baseline. This does not mean every person will regain the same amount. It does show that the effects observed during treatment may not persist unchanged after treatment ends.

SURMOUNT-4 used a randomized-withdrawal design after an initial tirzepatide treatment period. Participants assigned to continue tirzepatide maintained and added to their weight reduction on average, while participants switched to placebo experienced substantial weight regain. Again, these are study averages from a specific population and protocol. They support planning for obesity as a chronic condition rather than assuming medication effects will necessarily remain after treatment stops.

A long-term plan may include continued monitoring, nutrition and activity support, attention to strength and body composition, management of other health conditions, and discussion of whether another treatment strategy is appropriate. Baseline → Path → Progress still applies after a medication changes: understand the new baseline, choose the next path with a licensed clinician, and monitor progress over time.